The Coagulation Panel Test is a blood test that evaluates the body's blood clotting ability by measuring the time required for blood to form a clot. It helps assess the function of the coagulation system, detect bleeding or clotting disorders, monitor blood-thinning medications, and evaluate conditions affecting clot formation.
This test includes Prothrombin Time (PT), International Normalized Ratio (INR), Activated Partial Thromboplastin Time (APTT), and control values to provide information about different pathways involved in blood coagulation.
1.PT (INR) Value
The International Normalized Ratio, a standardised value calculated from PT; used mainly to monitor warfarin and similar blood thinners.
2.Prothrombin Time (PT)
Time blood takes to clot through the extrinsic and common pathways; helps assess clotting function, liver-related clotting problems and vitamin K deficiency.
3.APTT (Activated Partial Thromboplastin Time)
Time blood takes to clot through the intrinsic and common pathways; helps evaluate clotting factors, bleeding disorders and heparin therapy.
4.Control (MNAPTT)
The laboratory's mean normal APTT reference value, used for comparison with the patient's APTT result.
5.Control (MNPT)
The laboratory's mean normal prothrombin time reference value, used to calculate standardised PT and INR values.
Also known as: Coagulation Profile Test, Coagulation Function Test, Clotting Time Test, PT INR Test, Blood Clotting Test
The Coagulation Panel Test measures how effectively the blood clotting system works. Blood clotting is a complex process involving platelets and multiple clotting factors that prevent excessive bleeding after injury.
The test evaluates different pathways of the coagulation process:
Doctors use coagulation tests to diagnose clotting abnormalities, monitor anticoagulant therapy, and assess bleeding risks before certain medical procedures.
The test measures important parameters related to blood clot formation.
Prothrombin Time (PT):
Measures how long it takes blood to clot through the extrinsic and common coagulation pathways. PT helps evaluate the activity of certain clotting factors and is commonly used to assess:
A Coagulation Panel Test may be recommended for:
The test requires a blood sample collected from a vein.
Before the test:
| Parameter | Normal range |
|---|---|
| Prothrombin Time (PT) | Approximately 11–13.5 seconds |
| PT (INR) Value | Approximately 0.8–1.2 (for individuals not on anticoagulants) |
| APTT | Approximately 25–35 seconds |
| Control (MNPT) | Laboratory-specific |
| Control (MNAPTT) | Laboratory-specific |
| Note | Reference ranges may vary depending on laboratory methods, reagents used, medical conditions, and medications. INR targets may differ for patients receiving anticoagulant therapy. Results should always be interpreted by a qualified healthcare professional. |
Reference ranges can differ between labs. Your report shows the range used by the lab.
A Coagulation Panel Test is a blood test that evaluates how well your blood forms clots by measuring PT, INR, APTT, and related clotting parameters.
PT/INR is commonly used to monitor blood-thinning medicines such as warfarin and assess the body's clotting ability.
No. Fasting is generally not required unless your healthcare provider advises otherwise.
A high INR means blood is taking longer to clot. It may increase bleeding risk, especially in people taking anticoagulant medications.
| Test name | Coagulation Panel Test |
|---|---|
| Location | Udaipur |
| Sample type | Blood |
| Number of parameters | 5 |
| Home sample collection | Available |
| Fasting | Not required |
| Report time | As per laboratory processing time |
| Recommended age | 5–99 years |
| Suitable for | Male & Female |
A prolonged PT may be associated with:
PT (INR) Value:
The International Normalized Ratio (INR) is a standardized calculation based on PT results. INR is mainly used to:
A higher INR may indicate slower clot formation, while a lower INR may indicate faster clot formation.
APTT (Activated Partial Thromboplastin Time):
Measures the time required for blood clotting through the intrinsic and common coagulation pathways. It helps evaluate:
A prolonged APTT may occur due to:
Control (MNPT):
Control Mean Normal Prothrombin Time (MNPT) is a laboratory reference value used to compare patient PT results with normal clotting time. It helps laboratories calculate standardized PT and INR values.
Control (MNAPTT):
Control Mean Normal Activated Partial Thromboplastin Time (MNAPTT) is the laboratory reference value used for comparison with patient APTT results. It helps ensure accurate interpretation of APTT results.
Doctors may recommend a Coagulation Panel Test to:
The test may be advised if you experience:
Benefits of the Coagulation Panel Test:
A prolonged APTT may suggest clotting factor abnormalities, certain bleeding disorders, medication effects, or other medical conditions.
Yes. The liver produces many clotting factors, so liver problems can affect PT and other coagulation results.
Control values help laboratories compare patient results with normal clotting values and ensure accurate interpretation.
The Coagulation Panel Test evaluates clotting function but does not directly diagnose existing blood clots. Additional tests may be required.
Testing frequency depends on your medical condition, medications, treatment plan, and your healthcare provider's recommendation.
